Hengrui Medicine: has cumulatively spent 595 million yuan to repurchase 0.13% of the company's shares.

Hengrui Medicine announced that the company started repurchasing shares from August 20, 2025 for the implementation of the A-share employee stock ownership plan, with an expected repurchase amount of 1 billion to 2 billion RMB. As of November 30, a total of 8.8987 million shares have been repurchased, accounting for 0.13% of the total share capital, with a total payment of 595.2163 million RMB and a repurchase price ranging from 59.32 RMB per share to 70.00 RMB per share. In November, 979,900 shares were repurchased, accounting for 0.015%, with a total payment of 59.7885 million RMB and a price range of 59.32 RMB per share to 63.28 RMB per share.